These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9116967)

  • 1. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy.
    Sra J; Maglio C; Biehl M; Dhala A; Blanck Z; Deshpande S; Jazayeri MR; Akhtar M
    J Cardiovasc Electrophysiol; 1997 Jan; 8(1):42-6. PubMed ID: 9116967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midodrine hydrochloride in the treatment of vasovagal syncope.
    Mitro P; Trejbal D; Rybár AR
    Pacing Clin Electrophysiol; 1999 Nov; 22(11):1620-4. PubMed ID: 10598965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope.
    Grubb BP; Karas B; Kosinski D; Boehm K
    J Interv Card Electrophysiol; 1999 Jul; 3(2):139-43. PubMed ID: 10387140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midodrine: a role in the management of neurocardiogenic syncope.
    Ward CR; Gray JC; Gilroy JJ; Kenny RA
    Heart; 1998 Jan; 79(1):45-9. PubMed ID: 9505918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents.
    Grubb BP; Samoil D; Kosinski D; Kip K; Brewster P
    J Am Coll Cardiol; 1994 Aug; 24(2):490-4. PubMed ID: 8034887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study.
    Perez-Lugones A; Schweikert R; Pavia S; Sra J; Akhtar M; Jaeger F; Tomassoni GF; Saliba W; Leonelli FM; Bash D; Beheiry S; Shewchik J; Tchou PJ; Natale A
    J Cardiovasc Electrophysiol; 2001 Aug; 12(8):935-8. PubMed ID: 11513446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midodrine hydrochloride is safe and effective in older people with neurocardiogenic syncope.
    Paling D; Vilches-Moraga A; Akram Q; Atkinson O; Staniland JR; Paredes-Galán E
    J Am Geriatr Soc; 2010 Oct; 58(10):2026-7. PubMed ID: 20929474
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers.
    Klingenheben T; Credner S; Hohnloser SH
    Pacing Clin Electrophysiol; 1999 Feb; 22(2):276-81. PubMed ID: 10087541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A
    J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole.
    Sra JS; Jazayeri MR; Avitall B; Dhala A; Deshpande S; Blanck Z; Akhtar M
    N Engl J Med; 1993 Apr; 328(15):1085-90. PubMed ID: 8455666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial).
    Romme JJ; van Dijk N; Go-Schön IK; Reitsma JB; Wieling W
    Europace; 2011 Nov; 13(11):1639-47. PubMed ID: 21752826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of intravenous metoprolol during positive isoproterenol tilt-table test in the choice of treatment for neurocardiogenic syncope.
    Baran I; Gemici K; Ozdemir B; Saraç M; Güllülü S; Aydinlar A; Cordan J
    Indian Heart J; 2003; 55(1):40-3. PubMed ID: 12760586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope].
    Liu XY; Wang C; Wu LJ; Hu CY; Lin P; Li MX; Cui XL; Xie ZW
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1951-4. PubMed ID: 19950567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study.
    Kaufmann H; Saadia D; Voustianiouk A
    Ann Neurol; 2002 Sep; 52(3):342-5. PubMed ID: 12205647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of propantheline bromide in neurocardiogenic syncope: pharmacodynamic implications.
    Yu JC; Sung RJ
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):687-92. PubMed ID: 9110111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope.
    Qingyou Z; Junbao D; Chaoshu T
    J Pediatr; 2006 Dec; 149(6):777-80. PubMed ID: 17137891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study.
    Lamarre-Cliche M; Souich Pd; Champlain Jd; Larochelle P
    Clin Ther; 2008 Sep; 30(9):1629-38. PubMed ID: 18840368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of clonazepam in refractory neurally mediated syncope.
    Kadri NN; Hee TT; Rovang KS; Mohiuddin SM; Ryan T; Ashraf R; Huebert V; Hilleman DE
    Pacing Clin Electrophysiol; 1999 Feb; 22(2):307-14. PubMed ID: 10087545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of paroxetine in the treatment of refractory vasovagal syncope in young patients].
    Di Girolamo E; Di Iorio C; Leonzio L; Sabatini P; Ranalli G; Barsotti A
    G Ital Cardiol; 1999 Dec; 29(12):1472-7. PubMed ID: 10687110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Outcomes with Midodrine and Fludrocortisone for Objective Recurrence in Treating Syncope (COMFORTS trial): Rationale and design for a multi-center randomized controlled trial.
    Aminorroaya A; Tavolinejad H; Sadeghian S; Jalali A; Alaeddini F; Emkanjoo Z; Mollazadeh R; Bozorgi A; Oraii S; Kiarsi M; Shahabi J; Akbarzadeh MA; Rahimi B; Joharimoghadam A; Mohsenizade A; Mohammadi R; Oraii A; Ariannejad H; Apakuppakul S; Ngarmukos T; Tajdini M
    Am Heart J; 2021 Jul; 237():5-12. PubMed ID: 33689731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.